Microbial contributions to chronic inflammation and metabolic disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 4, 2016, Pages 257-262

  Shanahan, Fergus ^a   Sheehan, Donal ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

adipose tissue; antibiotics; bile acids; inflammation; microbes

Indexed keywords

ANTIBIOTIC AGENT; BILE SALT; SHORT CHAIN FATTY ACID; ANTIINFECTIVE AGENT;

CHRONIC INFLAMMATION; DIET; GLUCOSE METABOLISM; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LIPID STORAGE; METABOLIC DISORDER; MICROBIAL DIVERSITY; MICROFLORA; NONHUMAN; OBESITY; PERSONALIZED MEDICINE; REVIEW; RISK FACTOR; ANIMAL; DRUG EFFECTS; DYSBIOSIS; IMMUNOLOGY; IMMUNOPATHOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; DIET; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM DISEASES; METABOLIC DISEASES; PRECISION MEDICINE;

EID: 84964330988     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000282     Document Type: Review

References (48)

1. Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 2015; 33:227-256.
2. Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology 2015; 148:1107-1119.
3. Cox LM, Blaser MJ. Pathways in microbe-induced obesity. Cell Metab 2013; 17:883-894.
4. Brestoff J, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell 2015; 161:146-160.
5. Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity 2014; 40:843-854.
6. de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 2016; 13:13-27.
7. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 2016; 14:20-32.
8. Chimenti MS, Triggianese P, Conigliaro P, et al. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015; 6:e1887.
9. Khan MT, Nieuwdorp M, Bäckhed F. Microbial modulation of insulin sensitivity. Cell Metab 2014; 20:753-760.
10. von Hertzen L, Beutler B, Bienenstock J, et al. Helsinki alert of biodiversity and health. Ann Med 2015; 47:218-225.
11. Chassaing B, Gerwirtz AT. Has provoking microbiota aggression driven the obesity epidemic? Bioessays 2016; 38:122-128.
12. Shanahan F. The gut microbiota-a clinical perspective on lessons learned. Nat Rev Gastroenterol Hepatol 2012; 9:609-614.
13. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-227.
14. Shulzhenko N, Morgun A, Hsiao W, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 2011; 17:1585-1593.
15. Singh V, Yeoh BS, Carvalho F, et al. Proneness of TLR5 deficient mice to develop colitis is microbiota dependent. Gut Microbes 2015; 6:279-283.
16. Hooper LV. Epithelial cell contributions to intestinal immunity. Adv Immunol 2015; 126:129-172.
17. Levy M, Thaiss CA, Zeevi D, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 2015; 163:1428-1443.
18. Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med 2015; 66:343-359.
19. Kovatcheva-Datchary P, Nilsson A, Akrami R, et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab 2015; 22:971-982.
20. Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 2015; 163:1585-1595.
21. Camilleri M, Gores GJ. Therapeutic targeting of bile acids. Am J Physiol Gastrointest Liver Physiol 2015; 309:G209-G215.
22. Joyce SA, MacSharry J, Casey PG, et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci USA 2014; 111:7421-7426.
23. Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517:205-208.
24. Parséus A, Sommer N, Sommer F, et al. Microbiota-induced obesity requires farnesoid X receptor. Gut 2016. [Epub ahead of print]. doi: 10.1136/gutjnl-2015-310283.
25. Jiang C, Xie C, Lv Y, et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat Commun 2015; 6:10166.
26. Fang S, Suh JM, Reilly SM, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med 2015; 21:159-165.
27. Caesar R, Tremaroli V, Kovatcheva-Datchary P, et al. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 2015; 22:658-668.
28. Suárez-Zamorano N, Fabbiano S, Chevalier C, et al. Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat Med 2015; 21:1497-1501.
29. Shanahan F. Changing the narrative on antibiotics. Gut 2015; 64:1674-1675.
30. Schulfer A, Blaser MJ. Risks of antibiotic exposures early in life on the developing microbiome. PLoS Pathog 2015; 11:e1004903.
31. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol 2015; 11:182-190.
32. Morgun A, Dzutsev A, Dong X, et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 2015; 64:1732-1743.
33. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition corre lates with diet and health in the elderly. Nature 2012; 488:178-184.
34. Sonnenburg ED, Smits SA, Tikhonov M, et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 2016; 529:212-215.
35. Franzosa EA, Huang K, Meadow JF, et al. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci USA 2015; 112:E2930-E2938.
36. Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell 2015; 163:1079-1094.
37. Fu J, Bonder MJ, Cenit MC, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res 2015; 117:817-824.
38. Moeller AH, Foerster S, Wilson ML, et al. Social behaviour shapes the chimpanzee pan-microbiome. Sci Adv 2016; 2:e1500997.
39. Clemente JC, Pehrsson EC, Blaser MJ, et al. The microbiome of uncontacted Amerindians. Sci Adv 2015; 1:e1500183.
40. De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 2015. [Epub ahead of print]. doi: 10.1136/gutjnl-2015-309957.
41. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519:92-96.
42. Sinha R, Abnet CC, White O, et al. The microbiome quality control project: baseline study design and future directions. Genome Biol 2015; 16:276.
43. Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome 2015; 3:31.
44. Geva-Zatorsky N, Alvarez D, Hudak JE, et al. In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat Med 2015; 21:1091-1100.
45. Earle KA, Billings G, Sigal M, et al. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 2015; 18:478-488.
46. Wu H, Tremaroli V, Bäckhed F. Linking microbiota to human diseases: a systems biology perspective. Trends Endocrinol Metab 2015; 26:758-770.
47. Falony G, Vieira-Silva S, Raes J. Microbiology meets big data: the case of gut microbiota-derived trimethylamine. Annu Rev Microbiol 2015; 69:305-321.
48. Waldor MK, Tyson G, Borenstein E, et al. Where next for microbiome research? PLoS Biol 2015; 13:e1002050.